E. Zhu

发表

Artificial Anti-Tumor Opsonizing Proteins with Fibronectin Scaffolds Engineered for Specificity to Each of the Murine FcγR Types.

K. Wittrup, Tiffany F Chen, C. Opel, 2018, Journal of molecular biology.

Temporally Programmed CD8α+ DC Activation Enhances Combination Cancer Immunotherapy.

Ryan L. Kelly, D. Irvine, K. Wittrup, 2016, Cell reports.

Temporally Programmed CD8α[superscrip +] DC Activation Enhances Combination Cancer Immunotherapy

Ryan L. Kelly, D. Irvine, K. Wittrup, 2016 .

Redox Interfaces for Electrochemically Controlled Protein–Surface Interactions: Bioseparations and Heterogeneous Enzyme Catalysis

T. A. Hatton, T. Jamison, Xiao Su, 2017 .

Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.

D. Irvine, M. Yaffe, M. Mihm, 2015, Cancer cell.

Synergistic anti-tumor immune response to combination immunotherapy consisting of anti-tumor antibodies, extended half-life Interleukin-2, and other immunomodulatory agents

E. Zhu, Eric F. Zhu, 2016 .

Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses

Ryan L. Kelly, D. Lauffenburger, D. Irvine, 2016, Nature Medicine.

Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses

G. Dranoff, R. Hynes, J. Cochran, 2017, The Journal of experimental medicine.

Koch Institute Symposium on Cancer Immunology and Immunotherapy

Adam Drake, Darrell J Irvine, Nikhil S. Joshi, 2013, Cancer Immunology Research.